Lyle J. Arnold
Founder at Aegea Biotechnologies, Inc.
Profile
Lyle J.
Arnold is the founder of Molecular Biosystems, Inc. (1980), Oasis Biosciences, Inc. (2001), and Aegea Biotechnologies, Inc. (2010).
At Oasis Biosciences, Inc., he held the title of President & Chief Scientific Officer from 2001 to 2003.
At Aegea Biotechnologies, Inc., he holds the title of President, Chief Executive Officer & Director from 2010 to present.
Dr. Arnold's former jobs include Director at Asuragen, Inc. (2010-2016), Vice President-Research at Gen-Probe, Inc. (2003-2009), and Chief Scientific Officer & Senior Vice President at Biocept, Inc. (2013-2022).
He was also a Member at UC San Diego Moores Cancer Center.
Dr. Arnold received his undergraduate degree from the University of California, Los Angeles and his doctorate from the University of California San Diego.
Lyle J. Arnold active positions
| Companies | Position | Start |
|---|---|---|
Aegea Biotechnologies, Inc.
 Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Founder | 31/01/2010 |
Former positions of Lyle J. Arnold
| Companies | Position | End |
|---|---|---|
| BIOCEPT, INC. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Director/Board Member | 30/11/2016 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Oasis Biosciences, Inc.
 Oasis Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Oasis Biosciences, Inc. is a biotechnology company. The private company is based in San Diego, CA. The company was founded by Lyle J. Arnold, Bob D. Brown. | Chief Executive Officer | 31/08/2003 |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Founder | 31/12/1984 |
Training of Lyle J. Arnold
| University of California, Los Angeles | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOCEPT, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Oasis Biosciences, Inc.
Oasis Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Oasis Biosciences, Inc. is a biotechnology company. The private company is based in San Diego, CA. The company was founded by Lyle J. Arnold, Bob D. Brown. | Commercial Services |
Aegea Biotechnologies, Inc.
Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Health Services |
| UC San Diego Moores Cancer Center |
- Stock Market
- Insiders
- Lyle J. Arnold
